11-48112913-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_002843.4(PTPRJ):c.282T>C(p.Asp94Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00172 in 1,614,152 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00093 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 8 hom. )
Consequence
PTPRJ
NM_002843.4 synonymous
NM_002843.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.63
Publications
2 publications found
Genes affected
PTPRJ (HGNC:9673): (protein tyrosine phosphatase receptor type J) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PTPRJ Gene-Disease associations (from GenCC):
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
- thrombocytopenia 10Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- colorectal cancerInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 11-48112913-T-C is Benign according to our data. Variant chr11-48112913-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2641771.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.63 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 8 AD,Unknown,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRJ | NM_002843.4 | c.282T>C | p.Asp94Asp | synonymous_variant | Exon 3 of 25 | ENST00000418331.7 | NP_002834.3 | |
PTPRJ | NM_001098503.2 | c.282T>C | p.Asp94Asp | synonymous_variant | Exon 3 of 9 | NP_001091973.1 | ||
PTPRJ | XM_017018085.2 | c.234T>C | p.Asp78Asp | synonymous_variant | Exon 3 of 25 | XP_016873574.1 | ||
PTPRJ | XM_047427374.1 | c.624T>C | p.Asp208Asp | synonymous_variant | Exon 3 of 17 | XP_047283330.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000927 AC: 141AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
141
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00124 AC: 311AN: 251350 AF XY: 0.00122 show subpopulations
GnomAD2 exomes
AF:
AC:
311
AN:
251350
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00180 AC: 2632AN: 1461880Hom.: 8 Cov.: 31 AF XY: 0.00178 AC XY: 1297AN XY: 727242 show subpopulations
GnomAD4 exome
AF:
AC:
2632
AN:
1461880
Hom.:
Cov.:
31
AF XY:
AC XY:
1297
AN XY:
727242
show subpopulations
African (AFR)
AF:
AC:
8
AN:
33480
American (AMR)
AF:
AC:
27
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26134
East Asian (EAS)
AF:
AC:
1
AN:
39696
South Asian (SAS)
AF:
AC:
96
AN:
86258
European-Finnish (FIN)
AF:
AC:
52
AN:
53420
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2369
AN:
1112004
Other (OTH)
AF:
AC:
79
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
148
296
445
593
741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000926 AC: 141AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000873 AC XY: 65AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
141
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
65
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
14
AN:
41556
American (AMR)
AF:
AC:
6
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
3
AN:
4812
European-Finnish (FIN)
AF:
AC:
5
AN:
10602
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
111
AN:
68026
Other (OTH)
AF:
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Aug 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
PTPRJ: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.